ALNYLAM PHARMACEUTICALS, INC. ($ALNY)
Filing Information
| Accession Number | 0001735276-26-000032 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 25, 2026 |
| Document | View SEC Filing |
Transactions
1
Total Shares
158
Total Value
$0.00
P&L
+inf% (+$49,322.86)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CSO & EVP, Head of Research | Common Stock | โ | Feb 23, 2026 | Grant/Award | 158 | $0.00 | $0.00 | 21,422 | Direct | โ | View Details |